Verily Life Sciences, a subsidiary of Google's parent company, Alphabet and Sanofi, a French multinational pharmaceutical company launched Onduo - a joint venture to improve diabetes care, the companies announced Monday.
The collaboration will leverage Verily's miniaturized electronics, analytics and consumer software with Sanofi's clinical expertise to create innovative treatments for diabetes patients, the companies said in a statement.
Onduo is designed to “help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine and professional care to enable simple and intelligent disease management,” they added.
Read Full Article »
